Background Hodgkin lymphoma (HL) is an uncommon B cell lymphoma. We assessed the
global, regional, and national burden of HL from 1990 to 2017, by gender, age, and social …

Background Hodgkin lymphoma is a lymphatic malignancy commonly found in cervical
lymph nodes. This study evaluated the worldwide incidence, mortality, associated risk …

Our study examines global patterns of Hodgkin lymphoma (HL) in 2020 and predicts the
future incidence and mortality burden in 2040 using IARC's GLOBOCAN estimates of the …

Hodgkin lymphoma (HL) demonstrates heterogenous histologic findings, clinical
presentation, and outcomes. Using the United States Surveillance, Epidemiology, and End …

In recent decades, attention has focused on reducing long-term, treatment-related morbidity
and mortality in Hodgkin lymphoma (HL). In the present study, we looked for trends in …

Purpose Studies in classical Hodgkin lymphoma (cHL) typically measure the time to events
from diagnosis. We evaluated the risk of relapse at event-free survival time points in cHL and …

Background The accurate information about lymphoma burden at national and provincial
levels remains unknown in China. Methods Following the general analytical strategy used in …

The epidemiology of Hodgkin lymphoma (HL) has always been a source of fascination to
researchers due to its heterogeneous characteristics of presentation. HL is an uncommon …

Background: Hodgkin lymphoma is uncommon in the US general population; however,
Hodgkin lymphoma risk is elevated in people with human immunodeficiency virus (HIV) …

Background: Non-Hodgkin lymphoma is a common hematologic malignancy. This article
aimed to estimate the trends of non-Hodgkin lymphoma (NHL) globally from 1990 to 2019 …